Tempus AI Book Value Per Share 2023-2025 | TEM
Current and historical book value per share for Tempus AI (TEM) from 2023 to 2025. Book value per share can be defined as the amount of equity available to shareholders expressed on a per common share basis. Tempus AI book value per share for the three months ending March 31, 2025 was $1.89.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $12.253B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.946B | 59.99 |
| Hims & Hers Health (HIMS) | United States | $12.884B | 133.86 |
| IRhythm Technologies (IRTC) | United States | $4.705B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.914B | 61.16 |
| Privia Health (PRVA) | United States | $2.805B | 191.75 |
| Hinge Health (HNGE) | United States | $2.743B | 0.00 |
| Schrodinger (SDGR) | United States | $1.958B | 0.00 |
| Enovis (ENOV) | United States | $1.904B | 10.62 |
| Phreesia (PHR) | United States | $1.677B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
| Omnicell (OMCL) | United States | $1.424B | 25.12 |
| Azenta (AZTA) | United States | $1.410B | 65.55 |
| 10x Genomics (TXG) | United States | $1.327B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.661B | 0.00 |
| Claritev (CTEV) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.623B | 0.00 |
| Talkspace (TALK) | United States | $0.518B | 154.75 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 824.67 |
| Outset Medical (OM) | United States | $0.362B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.276B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.095B | 3.61 |
| 111 (YI) | China | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |